From Cancer Data to Discovery - Advancing the Future of AI in Oncology / AI in oncology, Arturo Loaiza-Bonilla, cancer, ...

Myeloma Paper of the Day, November 9th, Suggested by Robert Orlowski / Awais Malik, Azalfa Lateef, BMC Cardiovascular ...

Medical Physics Expertise Takes Center Stage in the Growth of Theranostics / cancer, Carlos Uribe, IDMP, OncoDaily, Oncology, ...

Cancer Research Funding Opportunities to Know This November / Breast Cancer, Cancer research, childhood blood cancer, ...

European Commission Expands Melphalan Flufenamide Approval to Third-Line Treatment for Multiple Myeloma / dexamethasone, Drug ...

Navigating New Treatment Strategies in HER2-Positive Breast Cancer / Breast Cancer, cancer, Erika Hamilton, ESMO26, Heather ...

EPICC is Undergoing its Major Independent Mid-Term Evaluation / cancer, EPICC, Karen Canfell, OncoDaily, Oncology, Sydney ...

Diwakar Davar Reports 55.6% Pathologic Complete Response Rate with Pembrolizumab in cSCC / Amanda G. Paulovich, Amy Rose, ...

Robert Stone, Chief Executive Officer at City of Hope, shared on LinkedIn: “Over the past couple of months, I have had the ...

The Prognostic Significance of NR3C1 Promoter Methylation in Castration-Resistant Prostate Cancer / cancer, ...

From Training at MD Anderson and Vanderbilt to Leading in Medical Oncology / cancer, Cathy Eng, Chris Lieu, OncoDaily, ...

Welcoming AACR Leadership to Philadelphia / AACR, AACR Board of Directors, American Association for Cancer Research, Cancer ...